These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24492621)

  • 1. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
    Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
    Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
    J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters.
    Marceau J; Safronetz D; Martellaro C; Marzi A; Rosenke K; Feldmann H
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.
    Lo MK; Bird BH; Chattopadhyay A; Drew CP; Martin BE; Coleman JD; Rose JK; Nichol ST; Spiropoulou CF
    Antiviral Res; 2014 Jan; 101():26-9. PubMed ID: 24184127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus.
    Martinez VP; Padula PJ
    J Med Virol; 2012 Jan; 84(1):87-95. PubMed ID: 22095538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
    Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
    Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
    [No Abstract]   [Full Text] [Related]  

  • 11. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
    Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
    J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection.
    Tsuda Y; Safronetz D; Brown K; LaCasse R; Marzi A; Ebihara H; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1090-7. PubMed ID: 21987746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.
    Garrido JL; Prescott J; Calvo M; Bravo F; Alvarez R; Salas A; Riquelme R; Rioseco ML; Williamson BN; Haddock E; Feldmann H; Barria MI
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
    Chattopadhyay A; Aguilar PV; Bopp NE; Yarovinsky TO; Weaver SC; Rose JK
    Vaccine; 2018 Jun; 36(27):3894-3900. PubMed ID: 29807712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.
    Tober R; Banki Z; Egerer L; Muik A; Behmüller S; Kreppel F; Greczmiel U; Oxenius A; von Laer D; Kimpel J
    J Virol; 2014 May; 88(9):4897-907. PubMed ID: 24554655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.